The Health Resources and Services Administration on Friday released a new draft of guidance for hospitals and other health care organizations regarding the 340B section of the Public Health Service Act, a drug pricing program intended "to permit covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services."